Avilar Therapeutics

Curie.Bio launched on 14 February with $520m to provide $5m-$7m in seed financing per start-up, plus access to in-house expertise and external research services, to help new biopharmas generate enough

The Alliance for Regenerative Medicine reported on 22 November that cell and gene therapy companies have raised enough money already in 2021 to break the record set in 2020. Venture capital financings